ASX-listed soft-tissue regeneration company Aroa Biosurgery Limited (ASX:ARX) is engaged in the development, manufacturing, selling, and distribution of medical and surgical products to improve healing in the reconstruction of complex wounds and soft tissue. The Company’s products are developed from a proprietary Aroa ECM™ technology platform.

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK